Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Immuron (ASX:IMC): Clinical data imminent!
February 6, 2024
We spoke to Immuron CEO Steve Lydeamore about the clinical work it is doing with IMM-124e and IMM-529, its involvement with the Uniformed Services University and the Naval Medical Research Command, and the commercial opportunity for Travelan now that people are travelling again.
Check out the in-depth research on Immuron by Pitt Street Research!
What are the Best ASX Lifesciences Stocks to invest in right now?
Check our ASX buy/sell tips